All filters
Videos
Session 2 - Panel Discussion
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Michael Ninburg | Introduction Session 2
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Sylvie Deuffic-Burban, PhD | Best practice talk - France
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
IVHEM 2018 | Session 1 Panel discussion
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Constance Mukabatsinda, MD | Best practice talk - Rwanda
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
John Ward, MD | Introduction Session 1
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP | Best practice talk - Myanmar
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Yvan Hutin, MD, PhD | WHO - update on the performance indicator
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD | The economic barriers preventing elimination – the importance of an investment
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
John Ward | Keynote Lecture on the elimination movement
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Introduction Session 5 | Jeffrey Lazarus, PhD, MIH, MA
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Session 5 - Panel Discussion
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Best practice talk - USA | Timothy Morgan, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Videos
Best practice talk - Georgia | Amiran Gamkrelidze, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
CPK/PD Support for a Phase 1 Study of TBA-7371- Jerry Nedelman, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Bedaquiline appears to antagonize its own main metabolite’s QTcF interval prolonging effect- Lénaïg Tanneau, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
TPreclinical and Clinical Pharmacokinetics and Pharmacodynamics Analysis of Delamanid- Suresh Mallikaarjun, PHD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Translational pharmacokinetic modelling & simulation of an experimental long-acting injectable formulation of bedaquiline- An Vermeulen, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention- Anthony Podany, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Fluoroquinolones in the treatment of multidrug-resistant tuberculosis: experience from three US TB treatment centers- Charles Peloquin, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Clofazimine pharmacokinetics in South African patients with drug-resistant tuberculosis-Sean Wasserman, MBChB, MMed
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018